Fig. 4From: Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveysProportion of patients with previously known T2DM and newly detected dysglycaemia reaching different blood pressure (a) and LDL-C (b) targets in the total cohortBack to article page